FDAFDA · Food and drugs·Recall number D-0286-2023
DAPTOMYCIN (a)360MG in NS 18ML syringe (b)580MG IN NS 29ML syringe(c) 630MG IN NS 31.5ML used with a home pump; antibiotic, Rx only, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320
Published February 22, 2023 · Recall initiated: December 27, 2022
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of sterility assurance
What to do
Voluntary: Firm initiated · Telephone
Recall details
- Manufacturer
- Sentara Infusion Services
- Distributor
- Dispensed to Patients Nationwide.
- Lot
- Beyond Use Date: December 25-30, 2022
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.